The Flow Cytometry Laboratory (Flow Lab) was established by the University of Wisconsin Carbone Cancer Center (UWCCC) in 1988 to support the laboratory, translational and clinical research activities of our members. The mission of the Flow Lab is to provide state-of-the-art instrumentation, technical expertise, cutting edge and cost-effective services and high quality education programs to advance laboratory, translational and clinical cancer research through the use of flow cytometry and high content cell imaging. The Flow Lab currently provides services at two sites. The main laboratory is located at the Wisconsin Institutes for Medical Research (WIMR), on the west side of the UW-Madison campus and a satellite laboratory is operating at the McArdle Laboratory for Cancer Research (McArdle), on the central UW Madison campus. The Flow Lab maintains four benchtop flow cytometer analysis instruments, two high-speed sorting cytometers, a high-throughput bioimaging microscope, as well as a fluorescent microscope with camera and supporting instrumentation such as biosafety cabinets, centrifuges and incubators. The Flow Lab is staffed from 8;00am to 6;00pm Monday through Friday and instrumentation is available to trained users at all times. Through support from the Cancer Center Support Grant (CCSG), successful instrumentation grants, institutional funds and charges to users, the Flow Lab is able to provide the instrumentation and expertise needed to serve the diverse research needs of UWCCC members in areas relating to use of analytical flow cytometry, cell sorting and high content cell imaging.
The mission of the Flow Cytometry Laboratory is to provide state-of-the-art instruments, technical expertise, cutting edge services and high quality education programs to advance laboratory, translational and clinical cancer research through the use of flow cytometry and high content cell imaging.
|Goel, Shreya; Ferreira, Carolina A; Chen, Feng et al. (2018) Activatable Hybrid Nanotheranostics for Tetramodal Imaging and Synergistic Photothermal/Photodynamic Therapy. Adv Mater 30:|
|Wei, Weijun; Ehlerding, Emily B; Lan, Xiaoli et al. (2018) PET and SPECT imaging of melanoma: the state of the art. Eur J Nucl Med Mol Imaging 45:132-150|
|Yu, Bo; Wei, Hao; He, Qianjun et al. (2018) Efficient Uptake of 177 Lu-Porphyrin-PEG Nanocomplexes by Tumor Mitochondria for Multimodal-Imaging-Guided Combination Therapy. Angew Chem Int Ed Engl 57:218-222|
|Ehlerding, Emily B; Lacognata, Saige; Jiang, Dawei et al. (2018) Targeting angiogenesis for radioimmunotherapy with a 177Lu-labeled antibody. Eur J Nucl Med Mol Imaging 45:123-131|
|Shea, Michael P; O'Leary, Kathleen A; Wegner, Kyle A et al. (2018) High collagen density augments mTOR-dependent cancer stem cells in ER?+ mammary carcinomas, and increases mTOR-independent lung metastases. Cancer Lett 433:1-9|
|Conklin, Matthew W; Gangnon, Ronald E; Sprague, Brian L et al. (2018) Collagen Alignment as a Predictor of Recurrence after Ductal Carcinoma In Situ. Cancer Epidemiol Biomarkers Prev 27:138-145|
|Ko, Huaising C; Kimple, Randall J (2018) The Resident Individual Development Plan as a Guide for Radiation Oncology Mentorship. Int J Radiat Oncol Biol Phys 101:786-788|
|McDermott, Andrew J; Tumey, Tyler A; Huang, Mingwei et al. (2018) Inhaled Cryptococcus neoformans elicits allergic airway inflammation independent of Nuclear Factor Kappa B signalling in lung epithelial cells. Immunology 153:513-522|
|You, Xiaona; Kong, Guangyao; Ranheim, Erik A et al. (2018) Unique dependence on Sos1 in Kras G12D -induced leukemogenesis. Blood 132:2575-2579|
|Ferreira, Carolina A; Hernandez, Reinier; Yang, Yunan et al. (2018) ImmunoPET of CD146 in a Murine Hindlimb Ischemia Model. Mol Pharm 15:3434-3441|
Showing the most recent 10 out of 1528 publications